AI-generated summary
The authors prospectively treated 60 patients with melasma using a picosecond Alexandrite laser, comparing a diffractive lens array (41 patients) with a flat optic (19 patients). The authors report a 75.7% improvement in the Melasma Severity Index at 6 months with the diffractive array versus 57.2% with the flat optic, with lower recurrence in the diffractive group. The study is a small, non-randomized investigation from a single practice.
- Participants
- 60
- Who or what was studied
- Sixty patients with melasma, described as Asian patients in a sunny climate
- Limits stated in the abstract
- Small, single-practice, non-randomized prospective study with two treatment groups of unequal size and no control group stated in the abstract.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.lww.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.